Description | Shares | Value | |||
Long-Term Investments 97.3% | |||||
Common Stocks | |||||
Argentina 9.6% | |||||
Globant SA*(a) | 6,465 | $1,118,057 | |||
MercadoLibre, Inc.* | 2,658 | 2,989,240 | |||
4,107,297 | |||||
Brazil 9.6% | |||||
Arco Platform Ltd. (Class A Stock)* | 14,622 | 636,788 | |||
Lojas Renner SA | 84,379 | 664,317 | |||
Magazine Luiza SA | 115,867 | 1,784,910 | |||
Notre Dame Intermedica Participacoes SA | 45,140 | 578,901 | |||
Raia Drogasil SA | 18,785 | 449,158 | |||
4,114,074 | |||||
China 51.5% | |||||
Aier Eye Hospital Group Co. Ltd. (Class A Stock) | 111,277 | 719,933 | |||
Alibaba Group Holding Ltd., ADR* | 7,159 | 1,797,052 | |||
BeiGene Ltd., ADR* | 2,365 | 494,285 | |||
Bilibili, Inc., ADR* | 27,289 | 1,189,255 | |||
Burning Rock Biotech Ltd., ADR* | 21,527 | 538,175 | |||
Genetron Holdings Ltd., ADR* | 29,927 | 427,956 | |||
Hangzhou Tigermed Consulting Co. Ltd. (Class A Stock) | 34,440 | 530,961 | |||
Hangzhou Tigermed Consulting Co. Ltd. (Class H Stock)* | 35,000 | 451,595 | |||
Hansoh Pharmaceutical Group Co. Ltd., 144A* | 160,793 | 697,589 | |||
Innovent Biologics, Inc., 144A* | 178,945 | 1,099,314 | |||
JD.com, Inc., ADR* | 15,942 | 1,016,940 | |||
Jiangsu Hengrui Medicine Co. Ltd. (Class A Stock) | 130,799 | 1,766,340 | |||
Kweichow Moutai Co. Ltd. (Class A Stock) | 4,770 | 1,143,376 | |||
Li Ning Co. Ltd. | 278,305 | 899,265 | |||
Meituan Dianping (Class B Stock)* | 86,768 | 2,145,071 | |||
Silergy Corp. | 22,000 | 1,323,476 | |||
Tencent Holdings Ltd. | 37,856 | 2,583,970 | |||
WuXi AppTec Co. Ltd. (Class H Stock), 144A(a) | 80,082 | 1,207,448 | |||
Wuxi Biologics Cayman, Inc., 144A* | 49,976 | 1,032,504 | |||
Zai Lab Ltd., ADR* | 12,627 | 961,041 | |||
22,025,546 | |||||
India 3.1% | |||||
Asian Paints Ltd. | 13,619 | 311,813 | |||
Hindustan Unilever Ltd. | 12,193 | 359,656 | |||
MakeMyTrip Ltd.*(a) | 41,651 | 648,506 | |||
1,319,975 |
Description | Shares | Value | |||
Common Stocks (Continued) | |||||
Indonesia 2.6% | |||||
Ace Hardware Indonesia Tbk PT* | 4,561,072 | $546,834 | |||
Mitra Adiperkasa Tbk PT* | 12,561,080 | 590,668 | |||
1,137,502 | |||||
Poland 2.0% | |||||
Dino Polska SA, 144A* | 15,276 | 852,649 | |||
South Korea 7.1% | |||||
Kakao Corp. | 3,306 | 959,533 | |||
NAVER Corp. | 4,457 | 1,130,117 | |||
Samsung SDI Co. Ltd. | 2,861 | 960,930 | |||
3,050,580 | |||||
Taiwan 9.6% | |||||
MediaTek, Inc. | 38,000 | 907,575 | |||
Sea Ltd., ADR*(a) | 16,548 | 2,022,165 | |||
Taiwan Semiconductor Manufacturing Co. Ltd., ADR | 14,775 | 1,165,600 | |||
4,095,340 | |||||
Thailand 2.2% | |||||
CP ALL PCL | 289,093 | 634,400 | |||
Minor International PCL* | 545,362 | 317,465 | |||
951,865 | |||||
Total Long-Term Investments (cost $27,762,450) | 41,654,828 | ||||
Short-Term Investments 14.1% | |||||
Affiliated Mutual Funds | |||||
PGIM Core Ultra Short Bond Fund(w) | 1,537,544 | 1,537,544 |
Description | Shares | Value | |||
Affiliated Mutual Funds (Continued) | |||||
PGIM Institutional Money Market Fund (cost $4,484,852; includes $4,483,503 of cash collateral for securities on loan)(b)(w) | 4,486,657 | $4,486,208 | |||
Total Short-Term Investments (cost $6,022,396) | 6,023,752 | ||||
TOTAL INVESTMENTS 111.4% (cost $33,784,846) | 47,678,580 | ||||
Liabilities in excess of other assets (11.4)% | (4,886,046) | ||||
Net Assets 100.0% | $42,792,534 |
Below is a list of the abbreviation(s) used in the quarterly schedule of portfolio holdings: |
144A—Security was purchased pursuant to Rule 144A under the Securities Act of 1933 and, pursuant to the requirements of Rule 144A, may not be resold except to qualified institutional buyers. | |
ADR—American Depositary Receipt |
* | Non-income producing security. |
(a) | All or a portion of security is on loan. The aggregate market value of such securities, including those sold and pending settlement, is $4,345,422; cash collateral of $4,483,503 (included in liabilities) was received with which the Series purchased highly liquid short-term investments. In the event of significant appreciation in value of securities on loan on the last business day of the reporting period, the Series may reflect a collateral value that is less than the market value of the loaned securities and such shortfall is remedied the following business day. |
(b) | Represents security, or portion thereof, purchased with cash collateral received for securities on loan and includes dividend reinvestment. |
(w) | PGIM Investments LLC, the manager of the Series, also serves as manager of the PGIM Core Ultra Short Bond Fund and PGIM Institutional Money Market Fund. |